MEVROMETOSTAT (PF-06821497) IN COMBINATION WITH ENZALUTAMIDE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PREVIOUSLY TREATED WITH ABIRATERONE ACETATE: THE PHASE 3, RANDOMIZED MEVPRO-1 STUDY

被引：0
|
作者：
Neeraj, Agarwal [1 ]
Michael, T. Schweizer [1 ]
Elena, Castro [1 ]
Arun, A. Azad [1 ]
Daniel, J. George [1 ]
Jayeta, Chakrabarti [1 ]
Sujata, Narayanan [1 ]
Yiyun, Tang [1 ]
Karim, Fizazi [1 ]
机构：
[1] Univ Utah, Huntsman Canc Inst NCI CCC, Salt Lake City, UT USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2025年 / 43卷 / 03期
关键词：
D O I：
10.1016/j.urolonc.2024.12.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Comparative Effectiveness of Abiraterone and Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer in Taiwan
    Li, Pei-Yu
    Lu, Ying-Hao
    Chen, Chung-Yu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Frailty and survival among veterans treated with abiraterone or enzalutamide for metastatic castration-resistant prostate cancer
    Deol, Ekamjit S.
    Sanfilippo, Kristen M.
    Luo, Suhong
    Fiala, Mark A.
    Wildes, Tanya
    Mian, Hira
    Schoen, Martin W.
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (05)
  • [33] Frailty and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
    Deol, Ekamjit Singh
    Luo, Suhong
    Sanfilippo, Kristen Marie
    Eisen, Seth A.
    Schoen, Martin W.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [34] Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer
    Lin, Jianqing
    Elkon, Jacob
    Ricart, Brittany
    Palmer, Erica
    Zevallos-Delgado, Christian
    Noonepalle, Satish
    Burgess, Brooke
    Siegel, Robert
    Ma, Yan
    Villagra, Alejandro
    ONCOLOGIST, 2021, 26 (12): : E2136 - E2142
  • [35] Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)
    Morris, Michael J.
    Heller, Glenn
    Hillman, David W.
    Bobek, Olivia
    Ryan, Charles
    Antonarakis, Emmanuel S.
    Bryce, Alan H.
    Hahn, Olwen
    Beltran, Himisha
    Armstrong, Andrew J.
    Schwartz, Lawrence
    Lewis, Lionel D.
    Beumer, Jan H.
    Langevin, Brooke
    McGary, Eric C.
    Mehan, Paul T.
    Goldkorn, Amir
    Roth, Bruce J.
    Xiao, Han
    Watt, Colleen
    Taplin, Mary-Ellen
    Halabi, Susan
    Small, Eric J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (18) : 3352 - +
  • [36] Treatment of metastatic castration-resistant prostate cancer. Drug interaction potentials of abiraterone acetate and enzalutamide
    Lipp, H-P.
    Miller, K.
    UROLOGE, 2016, 55 (06): : 766 - 771
  • [37] Economic Outcomes in Patients with Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus Prednisone
    Ramaswamy, Krishnan
    Lechpammer, Stanislav
    Mardekian, Jack
    Huang, Ahong
    Schultz, Neil M.
    Sandin, Rickard
    Wang, Li
    Baser, Onur
    George, Daniel J.
    ADVANCES IN THERAPY, 2020, 37 (05) : 2083 - 2097
  • [38] Comparison of real-life data of abiraterone acetate and enzalutamide in metastatic castration-resistant prostate cancer
    Ayşe Demirci
    Cemil Bilir
    Burcu Gülbağcı
    İlhan Hacıbekiroğlu
    İbrahim V. Bayoğlu
    İrem Bilgetekin
    Sinan Koca
    Havva Y. Çınkır
    Nadiye Akdeniz
    Deniz Gül
    Ceyhun Varım
    Umut Demirci
    Berna Öksüzoğlu
    Scientific Reports, 11
  • [39] Early PSA progression in abiraterone/enzalutamide-treated patients with metastatic castration-resistant prostate cancer.
    Lopez-Campos, Fernando
    Gomez-Iturriaga, Alfonso
    Llacer Perez, Casilda
    Henriquez, Ivan
    Peleteiro, Paula
    Lozano, Rebeca
    Castano, Ana
    Romero-Laorden, Nuria
    Molina-Cerrillo, Javier
    Alvarez-Rodriguez, Sara
    Piquer, Teresa
    Navarro-Castellon, Joaquin
    Jose Conde-Moreno, Antonio
    Ramirez-Backhaus, Miguel
    Barrionuevo, Patricia
    Garcia, Raquel
    de los Llanos Perez-Haro, Maria
    Castro, Elena
    Olmos, David
    Lorente, David
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Comparison of real-life data of abiraterone acetate and enzalutamide in metastatic castration-resistant prostate cancer
    Demirci, Ayse
    Bilir, Cemil
    Gulbagci, Burcu
    Hacibekiroglu, Ilhan
    Bayoglu, Ibrahim, V
    Bilgetekin, Irem
    Koca, Sinan
    Cinkir, Havva Y.
    Akdeniz, Nadiye
    Gul, Deniz
    Varim, Ceyhun
    Demirci, Umut
    Oksuzoglu, Berna
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345